-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

605.O1.6 605. Molecular Pharmacology and Drug Resistance: Lymphoid Neoplasms: Mechanisms of Therapy Resistance in Lymphoma

Symposia: Molecular Pharmacology and Drug Resistance: Lymphoid Neoplasms Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Lymphoid Leukemias, ALL, Combination therapy, Apoptosis, Fundamental Science, Adult, Translational Research, Lymphomas, Non-Hodgkin lymphoma, Drug development, B Cell lymphoma, Genomics, Bioinformatics, Plasma Cell Disorders, Diseases, Treatment Considerations, Immunology, Adverse Events, Lymphoid Malignancies, Biological Processes, Technology and Procedures, Profiling, Study Population, Human, Pathogenesis, Omics technologies
Monday, December 9, 2024: 2:45 PM-4:15 PM
Ballroom 20CD (San Diego Convention Center)
Moderators:
Johannes Christian Hellmuth, MD, LMU Munich and Coraline Mlynarczyk, PhD, Yale University
Disclosures:
No relevant conflicts of interest to declare.
2:45 PM

Caroline A. Coughlin, BS1, Dhanvantri Chahar, PhD2*, Marianna Lekakis2*, Hsuan-Ting Huang, PhD2, Abdessamad Youssfi Alaoui, PhD3*, Lingxiao Li4*, Evan Roberts5*, Natalia Campos Gallego6*, Claude-Henry Volmar2*, Ola Landgren5,7, Shaun Brothers2*, Anthony Griswold2*, Catalina Amador, MD8*, Daniel Bilbao, PhD9,10, Francesco Maura, MD11,12 and Jonathan H. Schatz, MD13,14,15

1University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL
2University of Miami Miller School of Medicine, Miami, FL
3Division of Hematology, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL
4GenScript ProBio, Nanjing, China
5Sylvester Comprehensive Cancer Center, Miami, FL
6University of Miami, miami, FL
7Sylvester Comprehensive Cancer Center, Myeloma Division, University of Miami, Miami, FL
8Division of Hematopathology, University of Miami, Miami, FL
9Cancer Modeling Shared Resource, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
10Department of Pathology and Laboratory Medicine, University of Miami Miller School of Medicine, Miami, FL
11University of Miami, Coral Gables, FL
12University of Miami, Palmetto Bay, FL
13Department of Hematology, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL
14University of Miami, Miami, FL
15Sylvester Comprehensive Cancer Center, University of Miami Miller School Medicine, Miami, FL

3:00 PM

Carolin S. Escherich, MD1*, Zhenhua Li, PhD2, Kelly R. Barnett, PhD3*, Yizhen Li, PhD3*, Megan Walker, PhD3*, Wenjian Yang, PhD2*, Xin Huang, PhD3*, Jiyang Yu, PhD3*, Wendy Stock, MD4, Elisabeth Paietta, PhD5*, Marina Konopleva6, Steven M. Kornblau, MD7, Mark R. Litzow, MD8, Hiroto Inaba, MD, PhD3, Ching-Hon Pui, MD3, Mignon L. Loh, MD, PhD9, Daniel Savic, PhD3 and Jun J. Yang, PhD3

1St. Jude Children’S Research Hospital, Memphis, TN
2Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN
3St. Jude Children's Research Hospital, Memphis, TN
4University of Chicago, Chicago, IL
5Department of Oncology, Montefiore Medical Center, Bronx, NY
6Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, Bronx, NY
7Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
8Division of Hematology, Mayo Clinic, Rochester, MN
9Ben Towne Center for Childhood Cancer Research, Seattle Children’s Hospital, Fred Hutch Cancer Center, University of Washington, Seattle, WA

3:15 PM

Maurizio Di Liberto, PhD1*, Yang Hu, PhD1*, Xiangao Huang, PhD1*, Giorgio Inghirami, MD1*, Kevin Wang, MD1*, Christina Y. Lee, MD1, Kami J. Maddocks, MD2, Kristie A. Blum, MD3, Jia Ruan, MD, PhD4, John P. Leonard, MD1, Nancy L. Bartlett, MD5, Peter Martin, MD4, Olivier Elemento, PhD, MS, BS6 and Selina Chen-Kiang, PhD7

1Weill Cornell Medicine, New York, NY
2The James Cancer Center, The Ohio State University, Columbus, OH
3Winship Cancer Institute of Emory University, Atlanta, GA
4Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY
5Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
6Englander Institute for Precision Medicine/ Weill Cornell Medicine, Weill Cornell Medicine, New York, NY
7Weill-Cornell Medical College, New York, NY

3:30 PM

Yuting Yan, MD1*, Dandan Shan2*, Ying Yu3*, Weihao Chen4*, Xinyi Zhang2*, Xiong Wenjie, MD1*, Tingyu Wang1*, Mu Hao, MD5*, Gang An5*, Lu-Gui Qiu5, Zhen Yu6* and Shuhua Yi7*

1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
2Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
3State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical Colleg, Tianjin, China
4State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjjn, China
5State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
6State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, CHN
7State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences&Peking Union Medical College, Tianjin, China

3:45 PM

Yu Zhang1*, Cong Wang2*, Tiange Lu1*, Ran Kong3*, Liemei Lv3*, Mei Ding1* and Xiangxiang Zhou, MD1

1Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China
2Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, AL, China
3Department of Hematology, Shandong Provincial Hospital, Shandong University, Jinan, China

4:00 PM

Shirong Liu, MD, PhD1, John M Hatcher, PhD1*, Amanda Kofides, BA1*, Alexa G Canning, BA1*, Dominic Pizzarella1*, Jinhua Wang, PhD2*, Xia Liu, MD1*, Nickolas Tsakmaklis1*, Maria Luisa Guerrera, MD1, Christopher J Patterson, MPH, MBA1*, Zachary R Hunter, PhD1, Shayna R Sarosiek1, Jorge J. Castillo, MD1, Sara J. Buhrlage, PhD2* and Steven P. Treon, MD, PhD, FRCP1

1Dana-Farber Cancer Institute, Bing Center for Waldenström Macroglobulinemia, Boston, MA
2Dana-Farber Cancer Institute, Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA

*signifies non-member of ASH